Abstract
Many cells, when cultured in suspension, fail to express cyclin A, a regulatory component of cell cycle kinases cdc2 and cdk2 and as a consequence, do not enter S phase. However, many cell type-specific differences are disclosed between not only normal and transformed cells, but also between cell lines whose proliferation is strictly anchorage-dependent. These apparent discrepancies are seen in established cell lines most probably because of adaptative events that have occurred during cell culture. We have therefore used primary cells to understand how cyclin A transcription is controlled by cell anchorage properties. To this aim, we have used embryonic fibroblasts from either wild type, Rb(−/−) or p107(−/−)/p130(−/−) mice and tested the effect of an ectopic expression of Rb mutants. In the experiments reported here, we show that anchorage-dependent expression of cyclin A (i) is reflected by the in vivo occupancy of a negative DNA regulatory element previously shown to be instrumental in the down regulation of cyclin A transcription in quiescent cells (Cell Cycle Responsive Element: CCRE) (ii) requires a functional Rb but neither p107 nor p130 (iii) mutation of the CCRE abolishes both adhesion-dependent regulation and response to Rb.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Assoian RK and Zhu X. . 1997 Curr. Opin. Cell Biol. 9: 93–98.
Barlat I, Fesquet D, Bréchot C, Henglein B, Dupuy d'Angeac A, Vié A and Blanchard JM. . 1993 Cell Growth Diff. 4: 105–113.
Barlat I, Henglein B, Plet A, Lamb N, Fernandez A, McKenzie F, Pouysségur J, Vié A and Blanchard JM. . 1995 Oncogene 11: 1309–1316.
Bos JL. . 1989 Cancer Res. 49: 4682–4689.
Carstens CP, Kramer A and Fahl WE. . 1996 Exp. Cell Res. 229: 86–92.
Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA and Jacks T. . 1996 Genes Dev. 10: 1633–1644.
Colburn NH, Vorder Bruegge WF, Bates JR, Gray RH, Rossen JD, Kelsey WH and Shimada T. . 1978 Cancer Res. 38: 624–634.
Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Brechot C and Sobczak-Thepot J. . 1995 Mol. Cell Biol. 15: 3301–3309.
Downward J. . 1997 Curr. Biol. 7: 258–260.
Fang F, Orend G, Watanabe N, Hunter T and Ruoslahti E. . 1996 Science 271: 499–502.
Freedman VH and Shin SI. . 1974 Cell 3: 355–359.
Girard F, Strausfeld U, Fernandez A and Lamb NJC. . 1991 Cell 67: 1169–1179.
Guadagno TM, Ohtsubo M, Roberts JM and Assoian RK. . 1993 Science 262: 1572–1575.
Hamel PA, Gill RM, Phillips RA and Gaillie BL. . 1992 Mol. Cell. Biol. 12: 3431–3438.
Henglein B, Chenivess X, Wang J, Eick D and Bréchot C. . 1994 Proc. Natl. Acad. Sci. USA 91: 5490–5494.
Herrera RE, Sah VP, Williams BO, Mäkelä TP, Weinberg RA and Jacks T. . 1996 Mol. Cell. Biol. 16: 2402–2407.
Huet X, Rech J, Plet A, Vié A and Blanchard JM. . 1996 Mol. Cell. Biol. 16: 3789–3798.
Hunter T and Pines J. . 1994 Cell 79: 573–582.
Hurford RK, Cobrinik D, Lee MH and Dyson N. . 1997 Genes Dev. 11: 1447–1463.
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigan SV, Stockert E, Day RS, Johnson BE and Skolnick MH. . 1994 Science 264: 436–439.
Kang JS and Krauss RS. . 1996 Mol. Cell. Biol. 16: 3370–3380.
Kramer A, Cartens CP and Fahl WE. . 1996 J. Biol. Chem. 271: 6579–6582.
Kramer A, Cartens CP, Wasserman WW and Fahl WE. . 1997 Cancer Res. 57: 5117–5121.
Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG and Livingston DM. . 1994 Cell 78: 161–172.
Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH and Bradley A. . 1992 Nature 359: 288–294.
Leone G, DeGregori J, Sears R, Jakoi L and Nevins JR. . 1997 Nature 387: 422–426.
Liu N, Lucibello FC, Engeland K and Müller R. . 1998 Oncogene 16: 2957–2963.
Liu N, Lucibello FC, Körner K, Wolfraim LA, Zwicker J and Müller R. . 1997 Nucl. Acids Res. 25: 4915–4920.
Mittnacht S, Paterson H, Olson MF and Marshall CJ. . 1997 Curr. Biol. 7: 219–221.
Nakamura T, Okuyama S, Okamoto S, Nakajima T, Sekiya S and Oda K. . 1995 Exp. Cell Res. 216: 422–430.
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. . 1994 Nature 368: 753–756.
Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G. . 1992 EMBO J. 88: 1039–1043.
Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA and Ewen ME. . 1997 Nature 386: 177–181.
Philips A, Huet X, Plet A, Le Cam L, Vié A and Blanchard JM. . 1998 Oncogene 16: 1373–1381.
Plet A, Huet X, Algarté M, Rech J, Imbert J, Philips A and Blanchard JM. . 1997 Oncogene 14: 2575–2583.
Qian Y, Luckey C, Horton L, Esser M and Templeton DJ. . 1992 Mol. Cell. Biol. 12: 5363–5372.
Sardet C, LeCam L, Fabrizio E and Vidal M. . 1997 In Oncogenes as transcriptional regulators, 2, Cell cycle regulators of chromosomal translocation. Yaniv M, Ghysdael J (eds).. Birkhäuser Verlag: Basel/Switzerland pp. 1–62.
Schulze A, Zerfass K, Bergès J, Middendorp S, Jansen-Dürr P and Henglein B. . 1996 Mol. Cell. Biol. 16: 4632–4638.
Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Bergès J, Helin K, Jansen-Dürr P and Henglein B. . 1995 Proc. Natl. Acad. Sci. USA 92: 11264–11268.
Sherr C. . 1996 Science 274: 1672–1677.
Shin SI, Freedman VH, Risser R and Pollack R. . 1975 Proc. Natl. Acad. Sci. USA 72: 4435–4439.
Taylor SJ and Shalloway D. . 1996 Curr. Biol. 6: 1621–1627.
Weinberg RA. . 1995 Cell 81: 323–330.
Yang W and Cerione RA. . 1997 J. Biol. Chem. 272: 24819–24824.
Yoshizumi M, Hsieh C, Zhou F, Tsai JC, Patterson C, Perrella MA and Lee ME. . 1995 Mol. Cell. Biol. 15: 3266–3272.
Zerfass-Thome K, Schulze A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B and Jansen-Dürr P. . 1997 Mol. Cell. Biol. 17: 407–415.
Zhu X, Ohtsubo M, Bohmer RM, Roberts JM and Assoian RK. . 1996 J. Cell Biol. 133: 391–403.
Zindy F, Lamas E, Chenivesse X, Sobczak J, Wang J, Fesquet D, Henglein B and Brechot C. . 1992 Biochem. Biophys. Res. Commun. 182: 1144–1154.
Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K and Müller R. . 1995 EMBO J. 14: 4514–4522.
Zwicker J and Müller R. . 1997 TIG 13: 3–6.
Acknowledgements
We thank N Dyson, D Cobrinick and P Hamel for their gifts of primary mouse fibroblasts and plasmids, and ML Vignais and R Hipskind for helpful discussions. AP was supported by a contract from the BIOMED2 program and XH by a fellowship from the Ligue Nationale Contre le Cancer (LNCC). This work was supported by grants from the BIOMED2 program, the ARC and LNCC.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Philips, A., Huet, X., Plet, A. et al. Anchorage-dependent expression of cyclin A in primary cells requires a negative DNA regulatory element and a functional Rb. Oncogene 18, 1819–1825 (1999). https://doi.org/10.1038/sj.onc.1202530
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202530